PharmiWeb.com - Global Pharma News & Resources
23-May-2019

Asklepios Kliniken: Revenue growth in first quarter of 2019

DGAP-News: Asklepios Kliniken / Key word(s): Quarterly / Interim Statement

23.05.2019 / 07:30
The issuer is solely responsible for the content of this announcement.


Asklepios: Revenue growth in first quarter of 2019

  • Consolidated revenue increases to EUR 875.6 million
  • Number of patients up 4.3% at 607,054
  • Investments increased by 23% to EUR 62.6 million

Hamburg, 23 May 2019. Asklepios Kliniken GmbH & Co. KGaA started off the current financial year with an increase in revenue in the first quarter of 2019. This was based on rising numbers of patients. By contrast, consolidated net income (EAT) recorded a decline. Asklepios is maintaining its forecast for 2019 as a whole for now and will drive the planned growth with targeted investments.

In the period from January to March 2019, the Asklepios Group treated a total of 607,054 patients, 4.3% more than in the same period of the previous year (3M 2018: 582,186). Revenue in the first quarter of 2019 was up 3.3% year-on-year at EUR 875.6 million (3M 2018: EUR 847.4 million). The cost of materials ratio came to 21.2% (3M 2018: 21.5%). The staff costs ratio rose to 67.4% (3M 2018: 66.5%). Overall, consolidated net income (EAT) for the period from January to March 2019 amounted to EUR 13.3 million (3M 2018: EUR 28.9 million).

"In view of the major challenges on the hospital market, we need to enhance our business model on a long-term basis. We are therefore digitalising our processes and services, tapping new markets and expanding our revenue base," says Kai Hankeln, CEO of the Asklepios Group. "With our recently presented digitalisation strategy 'Digital HealthyNear', we are now significantly speeding up the pace of implementation again. Asklepios can thus keep growing sustainably and profitably even in a chronically underfunded healthcare system."

In the first quarter of 2019, Asklepios invested a total of EUR 62.6 million, including subsidies (3M 2018: EUR 50.7 million). The share of own funds came to 75.2% (3M 2018: 68.5%). "By 2024, we will invest more than a billion euros in our hospital network, with roughly half of this going on digitalisation," explains Hafid Rifi, CFO of the Asklepios Group. "These investments will give Asklepios an edge in the digital healthcare industry of the future. The cash flow this requires forms the basis for our investments. However, we are not satisfied with this development in the first quarter."

The Asklepios Group has a stable financial position. Its net debt amounted to EUR 1,086.0 million as at 31 March 2019 (31 December 2018: EUR 1,027.0 million). The ratio of net debt to EBITDA for the past 12 months was 2.7x (31 December 2018: 2.6x). Cash funds amounted to EUR 281.4 million (31 December 2018: EUR 351.6 million) and unused credit facilities totalled EUR 450.6 million. As such, Asklepios can continue to expand its corporate growth on the basis of sufficient financial resources.

Our report on the first quarter of 2019 and corporate news can be found at www.asklepios.com/ir.


About Asklepios

The healthcare group Asklepios Kliniken is among the leading private operators of hospitals and healthcare facilities in Germany. The hospital group stands for highly professional care of its patients with a clear commitment to medical quality, innovation and social responsibility. On this basis, Asklepios has been developing dynamically ever since it was founded nearly 35 years ago. The group currently has 160 healthcare facilities across Germany. Its facilities include acute hospitals providing all levels of care, specialist clinics, psychiatric and forensic facilities, rehabilitation clinics, nursing homes and medical centres. In the 2018 financial year, 2.3 million patients were treated in the Asklepios Group's facilities. The company has more than 47,000 employees.

IR Contact
Mirjam Constantin
Investor Relations
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3
61462 Königstein-Falkenstein
Tel: +49 61 74 90-1166
Fax: +49 61 74 90-1110
ir@asklepios.com

PR Contact:
Rune Hoffmann
Group Head of Corporate Communications & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226
22307 Hamburg
Tel.: +49 40 1818-82 6630
Fax: +49 40 1818-82 6639
presse@asklepios.com

Visit Asklepios on its website, Facebook, or YouTube:
www.asklepios.com
www.asklepios.com/ir
www.facebook.com/asklepioskliniken
www.youtube.com/asklepioskliniken



23.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Editor Details

Last Updated: 23-May-2019